Differential effects of serotonergic and catecholaminergic drugs on ingestive behavior
- PMID: 1365856
- DOI: 10.1007/BF02247717
Differential effects of serotonergic and catecholaminergic drugs on ingestive behavior
Abstract
The serotonergic agonists fenfluramine and fluoxetine and the catecholaminergic agonists amphetamine and phenylpropanolamine are well known to cause a reduction in intake in rats. In the studies reported here we investigated the effects of these drugs on the microstructure of licking behavior of the rat ingesting 0.4 M sucrose. The purpose was to examine the similarities in the behavioral effects within and between these two classes of anorectic agents. The serotonergic agonists fenfluramine and fluoxetine caused a reduction in intake primarily by reducing the size of bursts and clusters of licking within the test meal without affecting the duration of the meal, suggesting a reduction in the palatability of the test solution. The catecholamine agonists amphetamine and phenylpropanolamine reduced intake primarily by reducing the number of bursts and clusters without affecting their size, suggesting a fractionation in the organization of the normal pattern of ingestion. The differences between the two serotonin and the two catecholamine agonists on the microstructure of the licking behavior suggest a different effect of the two neurotransmitters on the motor system that controls ingestive behavior. The similarities between the two different agonists within each class suggests a common neurotransmitter mechanism responsible for these two different effects on the behavior of the animals.
Similar articles
-
Effects of systemic phenylpropanolamine and fenfluramine on serotonin activity within rat paraventricular hypothalamus.Physiol Behav. 1996 Jan;59(1):63-9. doi: 10.1016/0031-9384(95)02032-2. Physiol Behav. 1996. PMID: 8848492
-
Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.Brain Res. 1998 Jul 27;800(1):62-8. doi: 10.1016/s0006-8993(98)00497-1. Brain Res. 1998. PMID: 9685586
-
Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat.Psychopharmacology (Berl). 2000 Oct;152(3):256-67. doi: 10.1007/s002130000504. Psychopharmacology (Berl). 2000. PMID: 11105935
-
Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.Int J Obes Relat Metab Disord. 1992 Dec;16 Suppl 3:S43-50. Int J Obes Relat Metab Disord. 1992. PMID: 1338321 Review.
-
Preclinical pharmacology of fluoxetine, a serotonergic drug for weight loss.Am J Clin Nutr. 1992 Jan;55(1 Suppl):177S-180S. doi: 10.1093/ajcn/55.1.177s. Am J Clin Nutr. 1992. PMID: 1728830 Review.
Cited by
-
Analysis of licking microstructure provides no evidence for a reduction in reward value following acute or sub-chronic phencyclidine administration.Psychopharmacology (Berl). 2010 Apr;209(2):153-62. doi: 10.1007/s00213-010-1779-x. Epub 2010 Feb 10. Psychopharmacology (Berl). 2010. PMID: 20145910
-
Reversal of sibutramine-induced anorexia with a selective 5-HT(2C) receptor antagonist.Psychopharmacology (Berl). 2011 Apr;214(4):941-7. doi: 10.1007/s00213-010-2106-2. Epub 2010 Dec 8. Psychopharmacology (Berl). 2011. PMID: 21140257
-
The overlap between binge eating disorder and substance use disorders: Diagnosis and neurobiology.J Behav Addict. 2013 Dec;2(4):191-8. doi: 10.1556/JBA.2.2013.015. Epub 2013 Oct 15. J Behav Addict. 2013. PMID: 25215200 Free PMC article. Review.
-
Contributions of Pavlovian incentive motivation to cue-potentiated feeding.Sci Rep. 2018 Feb 9;8(1):2766. doi: 10.1038/s41598-018-21046-0. Sci Rep. 2018. PMID: 29426846 Free PMC article.
-
Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.J Neural Transm Gen Sect. 1994;96(3):165-77. doi: 10.1007/BF01294784. J Neural Transm Gen Sect. 1994. PMID: 7826568
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources